Name | (3S)-4-[(1R)-1-(2-Amino-4-chlorophenyl)ethyl]-3-(4-chlorophenyl)-7-iodo-1-[3-(4-methyl-1-piperazinyl)propyl]-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione |
---|---|
Synonyms |
(3S)-4-[(1R)-1-(2-amino-4-chlorophenyl)ethyl]-3-(4-chlorophenyl)-7-iodo-1-[3-(4-methylpiperazin-1-yl)propyl]-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione
(3S)-4-[(1R)-1-(2-Amino-4-chlorophenyl)ethyl]-3-(4-chlorophenyl)-7-iodo-1-[3-(4-methyl-1-piperazinyl)propyl]-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione 1H-1,4-Benzodiazepine-2,5-dione, 4-[(1R)-1-(2-amino-4-chlorophenyl)ethyl]-3-(4-chlorophenyl)-3,4-dihydro-7-iodo-1-[3-(4-methyl-1-piperazinyl)propyl]-, (3S)- |
Description | A small molecule inhibitor of HDM2-p53 interaction with FP IC50 of 0.7 uM; inhibits the proliferation of wt p53-expressing cell lines with average IC50 of 0.7 uM, stabilizes p53 protein levels, upregulates p53 target genes in a DNA damage-independent manner, and induces apoptosis in HepG2 cells; increases p21(waf1/cip1) levels in mice liver samples, synergizes the effect of doxorubicin both in culture and in an A375 xenograft model. |
---|---|
References | References 1. Koblish HK, et al. Mol Cancer Ther. 2006 Jan;5(1):160-9. View Related Products by Target MDM2-p53 |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 835.4±65.0 °C at 760 mmHg |
Molecular Formula | C31H34Cl2IN5O2 |
Molecular Weight | 706.444 |
Flash Point | 459.1±34.3 °C |
Exact Mass | 705.113403 |
LogP | 4.39 |
Vapour Pressure | 0.0±3.1 mmHg at 25°C |
Index of Refraction | 1.649 |